⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20357980 | 0.97 | IDO1 (0.50) | — | |
| Magnesium Chloride Anhydrous SCHEMBL28474826 | 0.89 | CYP1A2 (0.46) | — | |
| SCHEMBL20302526 | 0.89 | IDO1 (0.44) | — | |
| SCHEMBL1803971 | 0.83 | ESR1 (0.32) | — | |
| SCHEMBL310520 | 0.77 | CYP1A2 (0.56) | — | |
| SCHEMBL840261 | 0.75 | TP53 (0.50) | — | |
| SCHEMBL1806452 | 0.75 | — | — | |
| SCHEMBL2451123 | 0.75 | CYP1A2 (0.59) | — | |
| SCHEMBL22092391 | 0.75 | CYP1A2 (0.54) | — | |
| SCHEMBL1149394 | 0.73 | IDO1 (0.58) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2739 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240207253-A1 | Inhibitors of CDR1 for Reversal of Azole Drug Resistance in Fungal Infections | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 2024-06-27 | — | — | US | claimed |
| CN-117799197-A | Large-area electrochromic device and preparation method thereof | 绍兴百立盛新材料科技有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-114901702-B | Glycosaminoglycan derivative and application thereof | 深圳市海普瑞药业集团股份有限公司 | 2024-01-09 | — | — | CN | claimed |
| EP-3423429-B1 | MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY | UNIV DE MONCTON (CA) | 2023-07-12 | — | — | EP | claimed |
| WO-2023055427-A1 | SMALL MOLECULE ANTAGONISTS OF PF4 | NEW YORK BLOOD CENTER, INC. (US) | 2023-04-06 | — | — | WO | claimed |
| WO-2022245951-A1 | INHIBITORS OF CDR1 FOR REVERSAL OF AZOLE DRUG RESISTANCE IN FUNGAL INFECTIONS | UNM RAINFOREST INNOVATIONS (US) | 2022-11-24 | — | — | WO | claimed |
| CN-115260834-A | Sulfur-containing high-refractive-index ink composition and preparation method thereof | 西安思摩威新材料有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-114901702-A | Glycosaminoglycan derivative and application thereof | 深圳市海普瑞药业集团股份有限公司 | 2022-08-12 | — | — | CN | claimed |
| EP-4015512-A1 | OPTICALLY ACTIVE DEVICES | AMO Ireland (IE) | 2022-06-22 | — | — | EP | claimed |
| EP-2303331-B1 | OPHTHALMIC DEVICE HAVING THERAPEUTIC AGENT DELIVERY CAPABILITY AND METHOD OF FORMING SAME | ALCON INC (CH) | 2022-01-26 | — | — | EP | claimed |
| US-4181733-A | ANTIBIOTICS | MERCK & CO., INC. (US) | 1980-01-01 | — | — | US | claimed |
| US-4167630-A | Process for epimerizing beta-lactam antibiotic compounds, and related products | MERCK & CO., INC. (US) | 1979-09-11 | — | — | US | claimed |
| US-4138414-A | 2-Phenoxy and 2-phenylthio anthraquinone disperse dyes | SANDOZ LTD. (CH) | 1979-02-06 | — | — | US | claimed |
| US-4107432-A | ANTIBIOTICS | MERCK & CO., INC. (US) | 1978-08-15 | — | — | US | claimed |
| US-4077962-A | WATER INSOLUBLE, GREEN-YELLOW, SYNTHETIC FIBERS | BAYER AKTIENGESELLSCHAFT (DT) | 1978-03-07 | — | — | US | claimed |
| US-4058661-A | 7-Diacyl cephalosporins | MERCK & CO., INC. (US) | 1977-11-15 | — | — | US | claimed |
| US-4053286-A | ACYLATION | MERCK & CO., INC. (US) | 1977-10-11 | — | — | US | claimed |
| US-4051132-A | Process for epimerizing beta-lactam antibiotic compounds by means of an acid quench | MERCK & CO., INC. (US) | 1977-09-27 | — | — | US | claimed |
| US-4024156-A | Thiophene ethanolamines | AMERICAN HOME PRODUCTS CORPORATION (US) | 1977-05-17 | — | — | US | claimed |
| US-4014873-A | Process for the production of 7-acylamidocephalosporins | MERCK & CO., INC. (US) | 1977-03-29 | — | — | US | claimed |